Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on PK of YHD1119 in Healthy Male Volunteers
NCT03191136Phase 1Completed
- Sponsor
- Yuhan
- Start
- May 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pregabalin in Peripheral neuropathic pain (2 arms), sponsored by Yuhan. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to the Last Measurable Concentration. Started May 2017; status: completed.
02
Drugs
pregabalin
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT03191136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03191136.